Periodical consideration on the establishment of antitumor action in host and activation of peritoneal exudate cells by lentinan.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001201:Ascites; D005260:Female; D007111:Immunity, Cellular / Q000528:radiation effects; D007116:Immunization, Passive; D008198:Lymph Nodes / Q000166:cytology; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008813:Mice, Inbred ICR; D009368:Neoplasm Transplantation; D011134:Polysaccharides / Q000494:pharmacology* / Q000627:therapeutic use; D011830:Radiation Effects; D012510:Sarcoma 180 / Q000188:drug therapy / Q000276:immunology*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D011134:Polysaccharides